A 12R-lipoxygenase in human skin: Mechanistic evidence, molecular cloning, and expression

  1. William E. Boeglin,
  2. Richard B. Kim, and
  3. Alan R. Brash*
  1. Division of Clinical Pharmacology, Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232-6602
  1. Communicated by Bengt Samuelsson, Karolinska Institutet, Stockholm, Sweden (received for review February 25, 1998)

Abstract

A recognized feature of psoriasis and other proliferative dermatoses is accumulation in the skin of the unusual arachidonic acid metabolite, 12R-hydroxyeicosatetraenoic acid (12R-HETE). This hydroxy fatty acid is opposite in chirality to the product of the well-known 12S-lipoxygenase and heretofore in mammals is known only as a product of cytochrome P450s. Here we provide mechanistic evidence for a lipoxygenase route to 12R-HETE in human psoriatic tissue and describe a 12R-lipoxygenase that can account for the biosynthesis. Initially we demonstrated retention of the C-12 deuterium of octadeuterated arachidonic acid in its conversion to 12R-HETE in incubations of psoriatic scales, indicating the end product is not formed by isomerization from 12S-H(P)ETE via the 12-keto derivative. Secondly, analysis of product formed from [10R-3H] and [10S-3H]-labeled arachidonic acids revealed that 12R-HETE synthesis is associated with stereospecific removal of the pro-R hydrogen from the 10-carbon of arachidonate. This result is compatible with 12R-lipoxygenase-catalyzed formation of 12R-HETE and not with a P450-catalyzed route to 12R-HETE in psoriatic scales. We cloned a lipoxygenase from human keratinocytes; the cDNA and deduced amino acid sequences share ≤50% identity to other human lipoxygenases. This enzyme, when expressed in Hela cells, oxygenates arachidonic acid to 12-HPETE, >98% 12R in configuration. The 12R-lipoxygenase cDNA is detectable by PCR in psoriatic scales and as a 2.5-kilobase mRNA by Northern analysis of keratinocytes. Identification of this enzyme extends the known distribution of R-lipoxygenases to humans and presents an additional target for potential therapeutic interventions in psoriasis.

Footnotes

  • * To whom reprint requests should be addressed. e-mail: alan.brash{at}mcmail.vanderbilt.edu.

  • Data deposition: The sequence reported in this paper has been deposited in the GenBank database (accession no. AF038461).

  • ABBREVIATIONS:
    H(P)ETE,
    hydro(pero)xyeicosatetraenoic acid;
    PFB,
    pentafluorobenzyl;
    RT,
    reverse transcriptase;
    UTR,
    untranslated region
« Previous | Next Article »Table of Contents